Department of Psychiatry Faculty

Education

1970, B.A. Psychology, Yale College
1974, M.D., University of Maryland School of Medicine
1974-1978, Postdoctoral Fellow, Yale University School of Medicine
1978, Joined Yale faculty

Research Interest

Bruce J. Rounsaville, MD, is Professor of Psychiatry and has, since 1977, devoted his career to clinical research on drug abuse and affective disorders. His principal research areas are psychotherapy and psychosocial interventions with drug abusers, the interaction of behavioral treatments and pharmacotherapy of drug abusers, identification and diagnosis of drug abusers in clinical and community settings, psychiatric epidemiology with emphasis on problems related to psychiatric comorbidity in drug abusers and familial contribution to the development of drug abuse. Major accomplishments include introduction of the Dependence Syndrome construct into the diagnostic criteria for Substance Use Disorders in DSM-III-R (Rounsaville et al, 1986, Rounsaville et al, 1987) and service as Principal Investigator on clinical trials demonstrating the efficacy of Relapse Prevention treatment for cocaine dependence (Carroll et al, 1994, Carroll et al, 1998) and of naltrexone as treatment for alcohol dependence (O'Malley et al, 1992). He is currently Principal Investigator on two major Clinical Research Centers. The first Center is a VA supported Mental Illness Research, Education and Clinical Center (MIRECC) which focuses on improving the treatment of Veterans with comorbid substance abuse and psychiatric disorders. Nine major MIRECC projects approach dual diagnosis issues at three levels: health services research, treatment effectiveness research and neurobiological research. Projects are coordinated by a Core staff and support for pilot projects is made available on a competitive basis. The second Center focuses on development and evaluation of efficacy and effectiveness of innovative behavioral treatments for drug abusers.

Publications of Note

Rounsaville, B. J. (2004). Treatment of cocaine dependence and depression. Biological Psychiatry. 56, 803-9.

Rounsaville, B.J., Petry, N., & Carol, K. (2003). Single versus multiple drug focus in substance abuse clinical trials research. Drug and Alcohol Dependence, 70, 117-125.

Rounsaville, B.J., & Carroll, K.M. (2002). Commentary on the dodo verdict: So why aren’t we dodos yet? Clinical Psychology: Science & Practice, 9, 17-20.

Rounsaville B. J. (2002). Experience with ICD-10/DSM-IV substance use disorders. Psychopathology, 35, 82-8.

Rounsaville, B.J., Carroll, K.M., & Onken, L.S. (2001). NIDA’s stage model of behavioral therapies research: Getting started and moving on from Stage I. Clinical Psychology: Science & Practice, 8, 133-142.

Rounsaville, B.J., Carroll, K.M., & Onken, L.S. (2001). Methodological diversity and theory in the stage model: Reply to Kazdin. Clinical Psychology: Science & Practice, 8, 152-154.

Rounsaville, B.J., & Kosten, T.R. (2000). Treatment for opioid dependence: Quality and access. (Ed) JAMA, 283, 1337-1339.

Rounsaville, B.J., Weiss, R., & Carroll, K.M. (1999). Option for managing psychotropic medications in drug-abusing patients participating in behavioral therapies clinical trials. American Journal on Addictions, 8,178-189.

Rounsaville, B.J. & Carroll, K.M. (1998). Individual psychotherapy. In A.W. Graham & T. K. Schultz (eds.) Principles of Addiction Medicine, Second Edition, (pp. 631-652). Chevy Chase, MD: American Society of Addiction Medicine.

Rounsaville, B.J., Kranzler, H.R., Ball, S.A., Tennen, H., Poling, J.C., & Trifflemen, E. (1998). Personality disorders in substance abusers: Relation to substance use. Journal of Nervous and Mental Disease, 86, 87-95.

Rounsaville, B.J. & Carroll, K.M. (1997). Individual psychotherapy for drug abusers. In J.H. Lowinson, P. Ruiz, & R.B. Millman (eds.), Substance Abuse: A Comprehensive Textbook Third Edition (pp. 430-439). New York: Williams & Wilkins.

Rounsaville, B.J. (1995). Can psychotherapy rescue naltrexone treatment of opioid addiction? In L. S. Onken, J.D. Blaine, & J. J. Boren (eds.), Integrating Behavioral Therapies with Medications in the Treatment ofDrug Dependence. (NIDA Research Monograph Series Number 150, pp. 37-52, NIH Publication No. 95-3899). Rockville, MD: National Institute on Drug Abuse.

Rounsaville, B.J. (1995). Data and diagnosis, commentary on DSM IV field trial for substance use disorders: Major results. Drug & Alcohol Dependence, 38, 71-83.

Rounsaville, B.J. (1993). Review of Innovations in Alcoholism Treatment: State of the Art Reviews and Their Implications for Clinical Practice by Gerald J. Connors (ed.). Addiction, 93, 1596-1597.

Rounsaville, B.J. (1993). Rationale and Guidelines for using comparable measures to evaluate substance abusers. In B.J. Rounsaville (ed.), A Diagnostic Source Book for Drug Abuse Research and Treatment. (National Institute on Drug Abuse Research Monograph Series. NIH Pub. No. 93 3508, pp. 1-10,) Washington, DC: Supt. of Docs., U.S. Govt. Print. Off.

Rounsaville, B.J., & Carroll, K.M. (1993). Interpersonal psychotherapy for patients who abuse drugs. In M.M. Weissman & G.L. Klerman (eds.) New Applications of Interpersonal Psychotherapy (pp. 319 352). Washington, DC: American Psychiatric Association Press.

Rounsaville, B.J. (1993). A Diagnostic Sourcebook for Drug Abuse Research and Treatment. (National Institute on Drug Abuse Research Monograph Series. NIH Pub. No. 93 3508.) Washington, DC: Supt. of Docs., U.S. Govt. Print. Off.

Rounsaville, B.J., Bryant, K., Babor, T., Kranzler, H., & Kadden, R. (1993). Cross system agreement for substance use disorders: DSM III R, DSM IV, and ICD 10. British Journal of Addiction, 8, 337 348

Copyright © . Yale University School of Medicine, Psychiatry Department. All rights reserved.
Comments or suggestions to the site editor.

Home URL: http://info.med.yale.edu/ysm